Auteurs Plaisant M, Giorgetti-Peraldi S, Gabrielson M, Loubat A, Dani C, Peraldi P
PloS one Feb 2011
Deficiency in the extracellular signal-regulated kinase 1 (ERK1) protects leptin-deficient mice from insulin resistance without affecting obesity.Auteurs Jager J, Corcelle V, Grémeaux T, Laurent K, Waget A, Pagès G, Binétruy B, Le Marchand-Brustel Y, Burcelin R, Bost F, Tanti JF
Diabetologia Jan 2011
The combination of metformin and 2 deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells.Auteurs Ben Sahra I, Tanti JF, Bost F
Autophagy Jul 2010
The combination of metformin and 2-deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells.Auteurs Ben Sahra I, Tanti JF, Bost F
Autophagy Jul 2010
Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans.Auteurs Dray C, Debard C, Jager J, Disse E, Daviaud D, Martin P, Attané C, Wanecq E, Guigné C, Bost F, Tanti JF, Laville M, Vidal H, Valet P, Castan-Laurell I
American journal of physiology. Endocrinology and metabolism Jun 2010
Metformin in cancer therapy: a new perspective for an old antidiabetic drug?Auteurs Ben Sahra I, Le Marchand-Brustel Y, Tanti JF, Bost F
Molecular cancer therapeutics May 2010
Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells.Auteurs Ben Sahra I, Laurent K, Giuliano S, Larbret F, Ponzio G, Gounon P, Le Marchand-Brustel Y, Giorgetti-Peraldi S, Cormont M, Bertolotto C, Deckert M, Auberger P, Tanti JF, Bost F
Cancer research Mar 2010
Insulin induces REDD1 expression through hypoxia-inducible factor 1 activation in adipocytes.Auteurs Regazzetti C, Bost F, Le Marchand-Brustel Y, Tanti JF, Giorgetti-Peraldi S
The Journal of biological chemistry Déc 2009
Hypoxia decreases insulin signaling pathways in adipocytes.Auteurs Regazzetti C, Peraldi P, Grémeaux T, Najem-Lendom R, Ben-Sahra I, Cormont M, Bost F, Le Marchand-Brustel Y, Tanti JF, Giorgetti-Peraldi S
Diabetes Nov 2008
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.Auteurs Ben Sahra I, Laurent K, Loubat A, Giorgetti-Peraldi S, Colosetti P, Auberger P, Tanti JF, Le Marchand-Brustel Y, Bost F
Oncogene Jun 2008